Renal Disease Market; Propelled by Large Unmet Need and Excellent Reimbursement Provisions Representing 20 Percent of all Medicare Spending in 2015 alone!

“Renal disease Market”
The Analysis presents the study of Global Renal disease Market facilitating the regional and country wise analysis covering the strategic analysis of each market player and the market share they hold. published a Half-Cooked research report on “Global Renal disease Market Research Report – Forecast to 2023” reports to its database. – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2023.


The Global Renal disease market is growing at the CAGR of ~6.3% during the forecast period and expected to reach US$ 14291.2 million by 2023.

The report titled “Renal disease Market -Forecast to 2023″ is a direct appreciation by Market Research Future of the market potential of the Renal disease Market. The report intends to provide accurate and meaningful insights, both quantitative as well as qualitative. It can be said with high confidence level, that this report will satisfy the need for comprehensive insights needed to compete and beat other players in today’s winner takes all market!

Regional Analysis of Global Renal disease Market:

North America is expected to be the largest market for global renal disease banking on high incidence rate and the huge reimbursement. The kidney disease costs Medicare program more than USD 50 billion in 2015, representing more than 20 percent of all Medicare spending. The fee for service provisions of end stage renal diseases rose from USD 30.4 billion in 2012 to USD 30.9 billion in 2013, which represents a 1.6 % increase.

The European region is anticipated to be the second largest market led by Germany, France and the U.K. Asia-Pacific (APAC) is expected to generate the fastest growth led by China, and India. Asians have 1.4 times higher risk of developing renal diseases than Caucasians. Also Diabetes is the leading cause of renal diseases. According to American Kidney Fund, Inc. report, Diabetes is the leading cause of renal diseases causes responsible for a whopping 44% of all cases of kidney failure. India has approximately 50 million diabetes patients, which is anticipated to reach 87 million patients in 2030. Thus the diabetes capital of the world is the future market for the kidney diseases.

Middle east and Africa (ME&A) market is constrained by poor per capita income, low awareness and political conditions. However the African continent also displays the largest unmet need as Africans are almost 4 times at a higher risk to develop renal diseases as compared to Caucasians.

Prominent Players for Global Renal disease Market:

Sanofi, Abbott, Shire Pharmaceuticals Limited, NephroGenex, Inc., Amgen Inc., Baxter, Bristol-Myers Squibb Company, Pfizer Inc., Novartis AG, Keryx Biopharmaceuticals, Inc., and others.

Scenario of Global Renal disease Market:

Diseases of the nephrons of the kidney are termed as renal diseases or nephropathy or kidney diseases. The market for global renal disease is expected to generate US$ 14291.2 million at a CAGR growth of ~6.3% by the review period of 2023.

Dynamics of Global Renal disease Market:


Large and growing unmet need, low flexibility of demand for treatment due to the serious nature of the ailment, and growing screening are the critical drivers of the market. National Health Interview Survey, 2015, estimates that 4.9 million, representing 2.0 % of adults were diagnosed with kidney disease in 2015 alone. The low flexibility of demand for treatment is reflected by the large mortality rate of 15.1 deaths per 100,000 population, which makes renal disease the 9th largest cause of deaths in the U.S. thus a large market is easily comprehendible.

The growth is risk factors associated with kidney diseases such as alcoholism, high blood pressure, diabetes and others is the second important driver. According to the National Institute of Diabetes and Digestive and Kidney Diseases approximately half cases of kidney diseases are associated with diabetes, cardiovascular diseases and other ailments.

The high demand for sustenance treatment such as dialysis is further stimulation the market as can be seen from the data of National Institute of Diabetes and Digestive and Kidney Diseases which predict 468,000 U.S. patients are on dialysis with 661,000 Americans suffering from kidney failure. The figures for kidney transplant corresponds roughly to 193,000 patients in U.S. alone in 2015. Other drivers of the market are growing geriatric population, rising incomes and others.


High cost of treatment especially the dialysis equipment and kidney transplant surgeries are the critical restraints on the market.

Segments of Global Renal disease Market:

Global Renal disease Market has been segmented on the basis of type which comprise acute kidney problems (Prerenal, Postrenal, Renal), Chronic kidney diseases, and others. On the basis of diagnosis, it segmented into Blood Tests (Serum Creatinine, Glomerular Filtration Rate(GFR), Blood Urea Nitrogen (BUN), fasting blood glucose test), Urine test (Urinalysis, Protein urine test, Microalbuminuria test, Creatinine Clearance test), Imaging test (Ultrasound, CT Scan ), Removing a sample of kidney tissue for testing.

Type – acute kidney problems (pre-renal, post-renal, renal), chronic kidney diseases, and others.

Diagnosis – Blood Tests (serum creatinine, glomerular filtration rate (GFR), blood urea nitrogen (BUN), fasting blood glucose test), urine test (urinalysis, protein urine test, micro albuminuria test, creatinine clearance test), imaging test (ultrasound, CT scan), biopsy and others.

Treatment – Drugs (anti-hypertensive drugs, anti-hyperlipidemia drugs, anti-anemic drugs, anti-inflammatory drugs, diuretic and others), Dialysis (hemodialysis, peritoneal dialysis), kidney transplant (deceased-donor kidney transplant, living-donor kidney transplant, pre-emptive kidney transplant), surgery (nephrectomy and radical nephrectomy, nephron-sparing surgery (NSS), nephrolithotripsy, extracorporeal shock wave lithotripsy (ESWL), and others), diet control and others.

Major TOC of Global Renal Disease Market:

Chapter 1.    Report Prologue

Chapter 2.    Introduction
        2.1    Definition

        2.2    Scope Of The Study

              2.2.1    Research Objective

              2.2.2    Assumptions

              2.2.3    Limitations

        2.3    Market Structure

        2.4.    Market Segmentation

Chapter 3.    Research Methodology
        3.1    Research Process

        3.2    Primary Research

        3.3    Secondary Research

        3.4    Market Size Estimation

        3.5    Forecast Model

Chapter 4.    Market Dynamics
        4.1    Drivers

        4.2    Restraints

        4.3    Opportunities

        4.4    Mega Trends

        4.5    Macroeconomic Indicators

Chapter 5.    Market Factor Analysis
        5.1     Value Chain Analysis

        5.2     Porters Five Forces

        5.3     Demand & Supply: Gap Analysis

        5.4    Pricing Analysis

        5.5    Investment Opportunity Analysis

        5.6    Merger And Acquisition Landscape

        5.7    Upcoming Trends

              5.7.1     Market Trends

              5.7.2     Technological Trends

              5.7.3    Insurance & Regulations

              5.7.4     Others



About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Media Contact
Company Name: Market Research Future
Contact Person: Akash Anand
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune –
City: Pune
State: Maharashtra
Country: India